Interleukin-10 and liver diseases
Le Moine, O.; Louis, H.; Sermon, F.; Goldman, M.; Devière, J.
Acta Gastro-Enterologica Belgica 62(1): 1-8
1999
ISSN/ISBN: 1784-3227 PMID: 10333592 Document Number: 504513
Document emailed within 1 workday
Related Documents
Chu, C.-J.; Lu, R.-H.; Wang, S.-S.; Chang, F.-Y.; Lin, S.-Y.; Yang, C.-Y.; Lin, H.-C.; Chang, C.-Y.; Wu, M.-Y.; Lee, S.-D. 2007: Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease Hepato-Gastroenterology 54(79): 2045-2048Weinstein, J.A.; Taylor, J.M. 1987: Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid a mRNA by murine recombinant interleukin-1 Journal of Trauma 27(11): 1227-1232
Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Alecu, M.; Geleriu, L.; Coman, G.; Gălăţescu, L. 1998: The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis Romanian Journal of Internal Medicine 36(3-4): 251-259
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Réglier-Poupet, H.; Hakim, J.; Gougerot-Pocidalo, M.A.; Elbim, C. 1998: Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood European Cytokine Network 9(4): 633-638
Yokota, T. 2005: Class i cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 4): 187-192
Qiu, H.B.; Chen, D.C.; Pan, J.Q.; Liu, D.W.; Ma, S. 1999: Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages Zhongguo Yao Li Xue Bao 20(3): 271-275
Miyaji, T.; Morishita, M.; Fukuda, T. 1986: Liver diseases and computer diagnosis: diagnosis of liver diseases by computers using information on various protein components Rinsho Byori. Japanese Journal of Clinical Pathology 34 Spec no 67: 233-252
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Kilpinen, S.; Huhtala, H.; Hurme, M. 2002: The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals European Cytokine Network 13(1): 66-71
Toda, G.; Ikeda, Y.; Hashimoto, N.; Yamazaki, M.; Torii, M.; Oka, H. 1983: Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases Clinical and Experimental Immunology 54(3): 661-670
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Swiatkowska-Stodulska, R.; Bakowska, A. 2004: Serum interleukin-6 concentrations in patients with alcoholic liver disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(99): 255-259
Pizzolo, G. 1991: The soluble interleukin-2 receptor as a new biological marker in diseases Allergologia et Immunopathologia 19(4): 176-180
Virstiuk, N.H. 2004: Diagnostic value of soluble interleukin-2 receptors in patients with alcoholic liver disease Likars'ka Sprava 2004(3-4): 39-42
Scapoli, L.; Girardi, A.; Palmieri, A.; Martinelli, M.; Cura, F.; Lauritano, D.; Pezzetti, F.; Carinci, F. 2015: Interleukin-6 Gene Polymorphism Modulates the Risk of Periodontal Diseases Journal of Biological Regulators and Homeostatic Agents 29(3 Suppl 1: 111-116
Kacprzyk, F. 1995: The importance of interleukin 6 (IL-6) in pathogenesis and diagnosis of renal glomerular diseases Postepy Higieny i Medycyny Doswiadczalnej 49(4): 513-522